Get 20% lifetime commission for referring investors to digrin.com
here.
Minerva Neurosciences, Inc. ( NERV) - Key Metrics
NERV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | $0.37 | -$286.38 | -$286.38 |
| 2026Q1 | $0 | -$2.86 | -$123.62 | -$123.62 |
| 2025Q4 | $0 | -$25.51 | -$0.40 | -$0.40 |
| 2025Q3 | $0 | -$0.36 | -$0.39 | -$0.39 |
| 2025Q2 | $0 | -$0.43 | -$0.27 | -$0.27 |
NERV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 3.85 |
| 2026Q1 | 0% | -0.53 |
| 2025Q4 | 0% | -0.04 |
| 2025Q3 | 0% | -1.47 |
| 2025Q2 | 0% | -1 |
NERV
Price: $4.44
52 week price:
Earnings Per Share: -40.15 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 48300
Ebitda: -11.1 millionMarket Capitalization: 220.6 million